Zobrazeno 1 - 10
of 683
pro vyhledávání: '"Machiels, J"'
Autor:
Harrington, K.J., Cohen, E.E.W., Soulières, D., Dinis, J., Licitra, L., Ahn, M.-J., Soria, A., Machiels, J.-P., Mach, N., Mehra, R., Burtness, B., Swaby, R.F., Lin, J., Ge, J., Lerman, N., Tourneau, C. Le
Publikováno v:
In Oral Oncology December 2023 147
Autor:
Honoré, N., van Marcke, C., Galot, R., Helaers, R., Ambroise, J., van Maanen, A., Mendola, A., Dahou, H., Marbaix, E., Van Eeckhout, P., Longton, E., Magremanne, M., Schmitz, S., Limaye, N., Machiels, J.-P.
Publikováno v:
In Annals of Oncology December 2023 34(12):1175-1186
Autor:
van Herpen, C., Vander Poorten, V., Skalova, A., Terhaard, C., Maroldi, R., van Engen, A., Baujat, B., Locati, L.D., Jensen, A.D., Smeele, L., Hardillo, J., Martineau, V. Costes, Trama, A., Kinloch, E., Even, C., Machiels, J.-P.
Publikováno v:
In ESMO Open December 2022 7(6)
Autor:
Simonelli, M., Garralda, E., Eskens, F., Gil-Martin, M., Yen, C.-J., Obermannova, R., Chao, Y., Lonardi, S., Melichar, B., Moreno, V., Yu, M.-L., Bongiovanni, A., Calvo, E., Rottey, S., Machiels, J.-P., Gonzalez-Martin, A., Paz-Ares, L., Chang, C.-L., Mason, W., Lin, C.-C., Reardon, D.A., Vieito, M., Santoro, A., Meng, R., Abbadessa, G., Menas, F., Lee, H., Liu, Q., Combeau, C., Ternes, N., Ziti-Ljajic, S., Massard, C.
Publikováno v:
In ESMO Open October 2022 7(5)
Autor:
Keam, B., Machiels, J.-P., Kim, H.R., Licitra, L., Golusinski, W., Gregoire, V., Lee, Y.G., Belka, C., Guo, Y., Rajappa, S.J., Tahara, M., Azrif, M., Ang, M.K., Yang, M.-H., Wang, C.-H., Ng, Q.S., Wan Zamaniah, W.I., Kiyota, N., Babu, S., Yang, K., Curigliano, G., Peters, S., Kim, T.W., Yoshino, T., Pentheroudakis, G.
Publikováno v:
In ESMO Open December 2021 6(6)
Autor:
Bossi, P., Chan, A.T., Licitra, L., Trama, A., Orlandi, E., Hui, E.P., Halámková, J., Mattheis, S., Baujat, B., Hardillo, J., Smeele, L., van Herpen, C., Castro, A., Machiels, J.-P.
Publikováno v:
In Annals of Oncology April 2021 32(4):452-465
Publikováno v:
In Oral Oncology February 2021 113
Publikováno v:
In Annals of Oncology November 2020 31(11):1462-1475
Autor:
Galot, R., Le Tourneau, C., Guigay, J., Licitra, L., Tinhofer, I., Kong, A., Caballero, C., Fortpied, C., Bogaerts, J., Govaerts, A.-S., Staelens, D., Raveloarivahy, T., Rodegher, L., Laes, J.-F., Saada-Bouzid, E., Machiels, J.-P. *
Publikováno v:
In Annals of Oncology December 2018 29(12):2313-2327
Autor:
Psyrri, A., Fayette, J., Harrington, K., Gillison, M., Ahn, M.-J., Takahashi, S., Weiss, J., Machiels, J.-P., Baxi, S., Vasilyev, A., Karpenko, A., Dvorkin, M., Hsieh, C.-Y., Thungappa, S.C., Segura, P.P., Vynnychenko, I., Haddad, R., Kasper, Stefan, Mauz, P.-S., Baker, V., He, P., Evans, B., Wildsmith, S., Olsson, R.F., Yovine, A., Kurland, J.F., Morsli, N., Seiwert, T.Y.
Publikováno v:
Annals of Oncology, Vol. 34, no.3, p. 262-274 (2023)
Background: Patients with recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC) have a poor prognosis. The phase III KESTREL study evaluated the efficacy of durvalumab [programmed death-ligand 1 (PD-L1) antibody] with or without t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0e33f2f8ddab292b429b7b169452344
https://doi.org/10.1016/j.annonc.2022.12.008
https://doi.org/10.1016/j.annonc.2022.12.008